new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Rigshospitalet
Rigshospitalet Copenhagen University Hospital
Rigshospitalet Copenhagen Univertisy Hospital
Rigshospitalet Public University Hospital
Rigshospitalet Rh
  

Rigshospitalet patents

Recent patent applications related to Rigshospitalet. Rigshospitalet is listed as an Agent/Assignee. Note: Rigshospitalet may have other listings under different names/spellings. We're not affiliated with Rigshospitalet, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Rigshospitalet-related inventors




Date Rigshospitalet patents (updated weekly) - BOOKMARK this page
10/20/16Injectable pharmaceutical compositions comprising prostacyclin
09/01/16Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength
06/09/16Entrapment of radionuclides in nanoparticle compositions
04/28/16Injectable pharmaceutical compositions comprising adrenaline and citric acid
12/31/15Anti-pad2 antibodies and treatment of autoimmune diseases
07/30/15Chimeric inhibitor molecules of complement activation
07/23/15Loading technique for preparing radionuclide containing nanoparticles
05/14/15177-lu labeled peptide for site-specific upar-targeting
02/26/15Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest
01/08/15Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples
11/20/14Pet tracer for imaging of neuroendocrine tumors
05/01/14Therapeutic targeting of ficolin-3
02/13/14Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
10/17/13Genetic variations in the interleukin-6 receptor gene as predictors of the response of patients to treatment with interleukin-6 receptor inhibitors
10/03/13Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest
04/18/13Optical motion tracking of an object
04/26/12Ficolin-3 assay
01/26/12Detection of carcinoma in situ in semen specimens
12/01/11Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
03/24/11Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker ykl-40
03/10/11Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker
02/24/11Ykl-40 as a general marker for non-specific disease
07/21/16Polypeptide for the protection against heart ischemia-reperfusion injury
02/05/09Method for detecting, screening, and/or monitoring cancer in an individual
10/06/11Acetic acid and a buffer
04/10/14Active vitamin d or analogs thereof for use in in vivo or in vitro fertilization
02/21/13Test for male fertility







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Rigshospitalet in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Rigshospitalet with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';